Hyperprolactinemia References

Last updated: 24 January 2020
Reviewed by
  1. Molitch ME. Disorders of prolactin secretion. Endocrinol Metab Clin North Am. 2001 Sep;30(3):585-610. PMID: 11571932
  2. Gibney J, Smith TP, McKenna TJ. The impact on clinical practice of routine screening for macroprolactin. J Clin Endocrinol Metab. 2005 Jul;90(7):3927-3932. PMID: 15811931
  3. Serri O, Chik CL, Ur E, et al. Diagnosis and treatment of hyperprolactinemia. CMAJ. 2003 Sep;169(6):575-581. PMID: 12975226
  4. Pizone JJ, Katzelson L, Danila DC, et al. Primary medical therapy of micro- and macroprolactinomas in men. J Clin Endocrinol Metab. 2000 Sep;85(9):3053-3057
  5. Molitch ME. Medical treatment of prolactinomas. Endocrinol Metab Clin North Am. 1999 Mar;28(1):143-169. PMID: 10207689
  6. Verhelst J, Abs R, et al. Cabergoline in the treatment of hyperprolactinemia: a study of 455 patients. J Clin Endocrinol Metab. 1999 Jul;84(7):2518-2522. PMID: 10404830
  7. Disorders of the anterior pituitary and hypothalamus. Harrison's Online: McGraw-Hill Companies; 2003. http://harrisonsonline.com
  8. Thorner MO. Hyperprolactinemia. Comprehensive clinical endocrinology. 3rd ed. London: Mosby; 2002
  9. MedWormhttp://www.medworm.com/rss/index.php/Endocrinology/15/http://www.medworm.com/rss/medicalfeeds/specialities/Endocrinology.xml
  10. MedWorm http://www.medworm.com/rss/index.php/Pediatrics/33/ http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics-News.xml
  11. Shenenberger D. Hyperprolactinemia. eMedicine. http://emedicine.medscape.com. Oct 2005.
  12. Segu VB. Prolactinoma. http://emedicine.medscape.com/article/124634-overview. Aug 2002
  13. Melmed S, Casanueva FF, Hofmann AR, et al.. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.. J Clin Endocrinol Metab.. 2011 Feb;96(2):273-288. https://www.endocrine.org/~/media/endosociety/Files/Publications/Clinical%20Practice%20Guidelines/Diagnosis-Treatment-of-Hyperprolactinemia.pdf. doi: 10.1210/jc.2010-1692. Accessed 5 May 2014. PMID: 21296991
  14. Vilar L, Fleseriu M, Bronstein MD. Challenges and pitfalls in the diagnosis of hyperprolactinemia. Arq Bras Endocrinol Metabol. 2014 Feb;58(1):9-22. http://www.scielo.br/pdf/abem/v58n1/0004-2730-abem-58-1-0009.pdf. PMID: 24728159
  15. Barlier A, Jaquet P. Quinagolide – a valuable treatment option for hyperprolactinemia. Eur J Endocrinol. 2006 Feb;154(2):187-195. doi: 10.1530/eje.1.02075. PMID: 16452531
  16. Snyder PJ. Management of hyperprolactinemia. UpToDate. http://www.uptodate.com. Feb 2019.